Hover a dot or row, or tab through the dots · bars scaled to the largest round ($220M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-409474
First filed2021-08-10
Latest2021-08-10
Sought$220M
Sold$220M
Investors15
Exemptions506(b)
021-192640
First filed2013-03-01
Latest2013-03-01
Sought$340K
Sold$330K
Investors9
Exemptions506
Who backs Reify Health, Inc. — 5 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2021-08-10
Related persons
Name
Relationship
Clarification
Ralph J. Passarella
RelationshipExecutive Officer, Director
ClarificationMr. Passarella is the Chief Executive Officer of the Issuer.
Michael Lin
RelationshipExecutive Officer, Director
ClarificationMr. Lin is the Secretary of the Issuer.
David Fleshman
RelationshipDirector
Clarification—
Mark Fernandes
RelationshipDirector
Clarification—
Neeraj Agrawal
RelationshipDirector
Clarification—
Facts
As its latest Form D states them
Industry
Other Technology
State
Massachusetts (MA)
Exemptions
Rule 506(b); Rule 506
First filed
2013-03-01
Latest filing
2021-08-10
Who backs Reify Health, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)